Environment, Safety & Health

Environmental
Social
Governance

ESG

Policy

Safety Health and Environment (EHS) Policy

ST Pharm declares that we will fulfill corporate social responsibility by complying with the obligation to secure a safety and health environment across all business areas based on the management philosophy of respect for life.

Establish and operate the company regulations to comply with safety, health and environment related laws, international agreements, and client requirements.
Through the identification and improvement of potential hazards and risk factors, we take first into account of the safety and health environment throughout the entire process, from product design, production, distribution, use, up to disposal.
To achieve the goal of the safety and health environment, we strengthen investment activities and make active efforts to save resources and promote recycling.
To make a safe working environment, we secure the process safety technology and emergency response system based on preventive activities.
We actively participate in the activities for community safety and health environment and take the leading role in promoting the safety and health environment of the local community.

[EHS Policy_PDF]
[E Policy + E Goals + climate change Road map + SH Goals _ PNG]

Climate Change Response Strategy

As physical and transition risks associated with climate change increase, companies that fail to establish appropriate climate change response strategies are increasingly likely to suffer financial losses.

Overview of Scenario Analysis

ST Pharm continuously monitors the global environment and deeply understands the impact of climate change on corporate sustainability and management activities. For this reason, we conducted a climate change scenario analysis to systematically evaluate the risks and opportunities posed by climate change to our business operations and proactively manage them. In the process of scenario analysis, we secured the validity of the analysis through interviews with external experts and a climate change scenario analysis workshop, and applied various future climate change scenarios to assess the potential impact on our operations and establish response strategies.
[Scenario Analysis Methodology_PNG]

Climate Risk Analysis Results

ST Pharm conducted scenario-based assessments of the 25 selected climate change risks, analyzed the risk patterns under the 1.5°C and 4.0°C scenarios, and derived changes by period (short-term (~2030), medium-term (~2040), and long-term (~2050)) and the impact on business operations. In the 1.5°C scenario, climate change risk patterns revealed a significant surge in policy and regulatory risks, as well as an ongoing increase in transition risks. In the 4.0°C scenario, physical climate risks were increased sharply, and market and supply chain risks continued to grow.
[Result_PNG]

Climate Risk Management Framework

ST Pharm has set short-, medium-, and long-term time horizons for responding to climate change, and conducted scenario analyses accordingly. In detail, we have systematically analyzed climate change scenarios up to 2050, taking into account the achievement of our net zero carbon emissions target. Through this analysis, we assess the impact of climate change on our business operations and develop response strategies for sustainable growth. The analysis results will serve as an important basis for setting GHG reduction targets and establishing implementation plans, and will contribute to minimizing climate change risks in the long term.
[Frameworl_PNG]

Climate Change Indicators and Targets

GHG Emissions

Classification	Unit	2022	2023	2024
Total GHG emissions (Scope 1+2+3)	tCO2eq	67,799	74,127	73,933
GHG emissions (Scope 1+2)	tCO2eq	21,415	24,243	26,246
Scope 1	tCO2eq	326	395	422
Scope 2	tCO2eq	21,089	23,848	25,724
원단위 Scope 1 +2 배출량	tCO2eq/억원	8.589	8.507	9.551
원단위 Scope 1 +2 증감률	%	-	-0.96	12.28
Scope 3 배출량	tCO2eq	46,384	49,884	47,787
C1. 구매한 제품 및 서비스	tCO2eq	36,762	39,635	36,829
C2. 자본재	tCO2eq	42	17	27
C3. Scope 1, 2에 포함되지 않는 연료 및 에너지 활동	tCO2eq	6,214	7,041	7,718
C4. 업스트림 운송 및 유통	tCO2eq	1,111	662	698
C5. 사업장에서 발생한 폐기물	tCO2eq	836	839	937
C6. 구성원 출장	tCO2eq	215	284	331
C7. 구성원 통근	tCO2eq	815	848	874
C9. 다운스트림 운송 및 유통	tCO2eq	54	65	74
C10. 판매한 제품의 가공	tCO2eq	335	493	302
총 온실가스 배출량	tCO2eq	67,799	74,127	73,933

온실가스 배출량 검증의견서 KOR / ENG

ST Pharm employs a systematic governance structure to respond to climate change and strengthen environmental management, thereby promoting an effective climate change response. The Board of Directors serves as the highest decision-making body overseeing climate-related risks and opportunities, regularly reviewing climate change response and environmental management goals and achievements.

Environmental Social Governance